The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication rates
Abstract
Background: : We systematically reviewed all available data in the literature to determine the overall eradication rates of currently advised Helicobacter pylori eradication regimens and to resolve conflicting evidence on the impact of antimicrobial resistance on the eradication rates. Methods: : A comprehensive search of all published trials on H. pylori eradication therapy was carried out via an electronic database search, hand‐searching and checking reference lists of pharmaceutical companies and other reviews. Full papers and abstracts in the English language which study currently advised eradication regimes were included. Results: : 770 study‐arms were analysed. Mean eradication rates for bismuth based triple, proton pump inhibitor triple, quadruple and ranitidine bismuth citrate combination therapies vary from 65 to 92%. In case of nitroimidazole resistance, a drop in efficacy of up to 50% was found for bismuth‐based triple and proton pump inhibitor‐based triple therapies. For quadruple therapy, a significant difference in efficacy was found in the equal‐effects analysis; however, this could not be confirmed in the random‐effects analysis. In case of clarithromycin resistance, a mean drop in efficacy of 56% was found for one‐ and two‐week clarithromycin containing proton pump inhibitor‐triple therapies and of 58% for two‐week ranitidine bismuth citrate combined with clarithromycin therapies. For ranitidine bismuth citrate combined with clarithromycin and nitroimidazole, no difference in efficacy was found in case of nitroimidazole or clarithromycin resistance, but data are still scarce. Conclusions: : The cure rate with most regimens dropped significantly, in case of nitroimidazole‐resistant strains, compared to nitroimidazole‐susceptible strains. In case of clarithromycin resistance, the efficacy of most regimens is also decreased; however, data are still scarce. These data should allow physicians to make a better choice of an appropriate therapy for their patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
Marshall, B., & Warren, J. R. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91816-6 · Cited by 5,509
Helicobacter pylori Infection and the Risk of Gastric Carcinoma
Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., & Sibley, R. K. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251603 · Cited by 3,894
Bayerdörffer, E., Rudolph, B., Neubauer, A., Thiede, C., Lehn, N., Eidt, S., Stolte, M., & MALT Lyphoma Study Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)90113-2 · Cited by 959
Cure of duodenal ulcer associated with eradication of Helicobacter pylori
Rauws, E. A. J., & Tytgat, G. N. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)91301-p · Cited by 922
Antibiotic resistance in : Implications for therapy
GRAHAM, D. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70100-3 · Cited by 300
Treatment of Helicobacter pylori Infection: A Review of the World Literature
van Der Hulst, R. W. M., Keller, J. J., Rauws, E. A. J., & Tytgat, G. N. J. (1996) · Helicobacter · doi:10.1111/j.1523-5378.1996.tb00003.x · Cited by 289
Resistance of Helicobacter pylori to antibiotics
MÉGRAUD, F. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.11.s1.11.x · Cited by 242
Adamek, R. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(97)00110-x · Cited by 202
Results of a multicentre European survey in 1991 of metronidazole resistance inHelicobacter pylori
European Study Group on Antibiotic Susceptibility of Helicobacter pylori (1992) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01960875 · Cited by 138
Antibiotic resistance in Helicobacter pylori infection
Megraud, F. (1998) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011671 · Cited by 102
Cited by
Suerbaum, S., & Michetti, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020542 · Cited by 2,987
Evaluation of networks of randomized trials
Salanti, G., Higgins, J. P., Ades, A., & Ioannidis, J. P. (2008) · Statistical Methods in Medical Research · doi:10.1177/0962280207080643 · Cited by 1,078
H pylori antibiotic resistance: prevalence, importance, and advances in testing
Mégraud, F. (2004) · Gut · doi:10.1136/gut.2003.022111 · Cited by 955
Helicobacter pylori Detection and Antimicrobial Susceptibility Testing
Mégraud, F., & Lehours, P. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00033-06 · Cited by 725
Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications
Gerrits, M. M., van Vliet, A. H., Kuipers, E. J., & Kusters, J. G. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70627-2 · Cited by 329
Metadata
- Authors
- Houben, Beek, D. V. D., Hensen, Craen, A. J. M. D., Rauws, & Tytgat
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 1999-08
- Volume
- 13
- Issue
- 8
- Pages
- 1047-1055
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2134300124
- Cited by
- 333
- References
- 14
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication rates. https://app.cochat.ai/papers/10.1046/j.1365-2036.1999.00555.x
- The paper
- Houben, Beek, D. V. D., Hensen, Craen, A. J. M. D., Rauws, & Tytgat. (1999). A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication rates. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.1999.00555.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.